Essential Amino Acid Supplementation in Older Adult COVID-19 Patients

• Status: Withdrawn
• Trial end date: 2022-03-01
• Target enrollment: 0
• Participant gender: All

Summary

A 4-week treatment of essential amino acids or placebo to participants with: 1) negative COVID-19 test with exposure, or 2) positive COVID-19 test and no or mild symptoms. The study team will measure change in symptoms. Participants will complete symptom surveys for 4 weeks and once at 8 and 12 weeks as well as pre- and post-assessments.

• Phase: Phase 2/Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: University of Arkansas

Criteria

Inclusion Criteria:

• Exposure to COVID-19 in the last 60 days with no symptoms, with a COVID negative test Close contact: within 6 feet of a COVID-19 positive person for more than a few minutes without wearing PPE, or having direct contact with infectious secretions without PPE

• Positive COVID-19 test with or without symptoms

Exclusion Criteria:

• COVID-19 positive hospitalized patient

• Patients who have symptoms of COVID but have not been tested.

• Unable to tolerate oral intake

• In hospice or palliative care

• Unstable medical or psychiatric condition

• Other criteria deemed acceptable by principle investigator